SG2389G - Gamma-butyrolactone derivatives with myocardium protecting and antiarrhytmic activity,process for their preparation and medicines containing them - Google Patents

Gamma-butyrolactone derivatives with myocardium protecting and antiarrhytmic activity,process for their preparation and medicines containing them

Info

Publication number
SG2389G
SG2389G SG23/89A SG2389A SG2389G SG 2389 G SG2389 G SG 2389G SG 23/89 A SG23/89 A SG 23/89A SG 2389 A SG2389 A SG 2389A SG 2389 G SG2389 G SG 2389G
Authority
SG
Singapore
Prior art keywords
group
products
antiarrhytmic
gamma
activity
Prior art date
Application number
SG23/89A
Other languages
English (en)
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of SG2389G publication Critical patent/SG2389G/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57Nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
SG23/89A 1982-11-08 1989-01-11 Gamma-butyrolactone derivatives with myocardium protecting and antiarrhytmic activity,process for their preparation and medicines containing them SG2389G (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8218705A FR2535722B1 (fr) 1982-11-08 1982-11-08 Derives de la g-butyrolactone protecteurs du myocarde presentant une activite antiarythmique, procede pour leur preparation et medicaments en contenant

Publications (1)

Publication Number Publication Date
SG2389G true SG2389G (en) 1991-01-04

Family

ID=9278999

Family Applications (1)

Application Number Title Priority Date Filing Date
SG23/89A SG2389G (en) 1982-11-08 1989-01-11 Gamma-butyrolactone derivatives with myocardium protecting and antiarrhytmic activity,process for their preparation and medicines containing them

Country Status (29)

Country Link
US (1) US4542134A (no)
EP (1) EP0113600B1 (no)
JP (1) JPS59161379A (no)
KR (1) KR900006723B1 (no)
AT (1) ATE28644T1 (no)
AU (1) AU560032B2 (no)
CA (1) CA1224467A (no)
CS (1) CS244680B2 (no)
DD (2) DD231567A5 (no)
DE (1) DE3372767D1 (no)
DK (1) DK503683A (no)
ES (1) ES8406071A1 (no)
FI (1) FI79538C (no)
FR (1) FR2535722B1 (no)
GR (1) GR78746B (no)
HU (1) HU192825B (no)
IE (1) IE56208B1 (no)
IL (1) IL70062A (no)
MA (1) MA19947A1 (no)
NO (1) NO159853C (no)
NZ (1) NZ206176A (no)
OA (1) OA07581A (no)
PH (1) PH19547A (no)
PL (2) PL139945B1 (no)
PT (1) PT77606B (no)
SG (1) SG2389G (no)
SU (1) SU1279529A1 (no)
YU (2) YU220483A (no)
ZA (1) ZA837935B (no)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3714173A (en) * 1971-07-06 1973-01-30 Smith Kline French Lab Pyridyl ketipate lactones and derivatives
FR2467200A1 (fr) * 1979-10-11 1981-04-17 Clin Midy Derives du pyrrole actifs sur les troubles du rythme cardiovasculaire

Also Published As

Publication number Publication date
CS821983A2 (en) 1985-10-16
FR2535722A1 (fr) 1984-05-11
DK503683D0 (da) 1983-11-03
SU1279529A3 (ru) 1986-12-23
FR2535722B1 (fr) 1985-06-28
NO159853C (no) 1989-02-15
US4542134A (en) 1985-09-17
NZ206176A (en) 1985-12-13
IE56208B1 (en) 1991-05-22
GR78746B (no) 1984-10-02
EP0113600A1 (fr) 1984-07-18
ES527092A0 (es) 1984-07-01
PL142949B1 (en) 1987-12-31
KR840006646A (ko) 1984-12-01
SU1279529A1 (ru) 1986-12-23
FI834069A (fi) 1984-05-09
HU192825B (en) 1987-07-28
IE832580L (en) 1984-05-08
FI79538B (fi) 1989-09-29
FI79538C (fi) 1990-01-10
YU143585A (en) 1986-04-30
PH19547A (en) 1986-05-20
ZA837935B (en) 1984-06-27
OA07581A (fr) 1985-03-31
ATE28644T1 (de) 1987-08-15
CS244680B2 (en) 1986-08-14
IL70062A0 (en) 1984-01-31
AU560032B2 (en) 1987-03-26
DE3372767D1 (en) 1987-09-03
IL70062A (en) 1987-02-27
MA19947A1 (fr) 1984-07-01
YU220483A (en) 1986-04-30
DD231567A5 (de) 1986-01-02
NO834053L (no) 1984-05-09
FI834069A0 (fi) 1983-11-07
PL244461A1 (en) 1985-01-30
AU2063983A (en) 1984-05-17
PT77606B (fr) 1986-03-18
ES8406071A1 (es) 1984-07-01
DD220313A5 (de) 1985-03-27
DK503683A (da) 1984-05-09
NO159853B (no) 1988-11-07
PL139945B1 (en) 1987-03-31
JPS59161379A (ja) 1984-09-12
EP0113600B1 (fr) 1987-07-29
CA1224467A (en) 1987-07-21
PT77606A (fr) 1983-12-01
PL249775A1 (en) 1985-05-07
KR900006723B1 (ko) 1990-09-20

Similar Documents

Publication Publication Date Title
GR3005315T3 (no)
MY100095A (en) 2-oxo-imidazolidine compounds, a process for preparing the same and a pharmaceutical composition.
IL102093A0 (en) 1-methylcarbapenem derivatives,processes for the preparation thereof,and pharmaceutical compositions containing the same
FI822767A0 (fi) Foerfarande foer framstaellning av nya metyl-4-fenyl-6-pyridazin-derivat
PT77607A (fr) Procede de preparation de derives de la piperidinedione protecteurs du myocarde presentant une activite antiarythmique
EP0150015A3 (en) Norbornane and norbornene carboxylic acid amides, process for their preparation and their use as medicines
DE3372767D1 (en) Gamma-butyrolactone derivatives with myocardium protecting and antiarrhytmic activity, process for their preparation and medicines containing them
ES486580A1 (es) Un procedimiento para preparar compuestos con propiedades broncodilatadoras
DE3564106D1 (en) 4-phenylaminopyridine derivatives, process of the preparation thereof and pharmaceutical compositions containing them
GB2014995A (en) (Cycloalkyl)-alkylbenzamides